Veerhealth Care share news, announcements and annual reports
BSE: 511523Pharmaceuticals & BiotechnologySmall Cap
Veerhealth Care Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Sep 1994
Last close ₹48.99up ₹0.11 (0.23%)
Share price at the BSE close on 29 Oct 2026. Previous close ₹48.88.
29 Oct: open ₹48.30, high ₹49.49, low ₹48.20
52-week range of traded prices to 29 Oct 2026
₹16.70Low, 1 Feb 2026₹52.00High, 15 Sep 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹98 Cr3,569th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 64.03
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹0.31 crore of one-off items, the largest of them in the quarter to Mar 2026.
- 53.24
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 4.27
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 6.8%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹0.31 crore of one-off items, the largest of them in the quarter to Mar 2026.
- 8.2%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 11.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.20
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 87,888
Veerhealth Care board meetings
126 filed, newest first. Page 1 of 3.
Aug 2026
5 Aug · Board meeting
Meeting on 13 Aug 2026: quarterly results
Jul 2026
May 2026
25 May · Board meeting
Meeting on 30 May 2026: dividend and audited results
Mar 2026
20 Mar · Board meeting
Meeting on 28 Mar 2026: preferential issue of shares
Feb 2026
6 Feb · Board meeting
Meeting on 14 Feb 2026: quarterly results2 Feb · Board meeting
Nov 2025
6 Nov · Board meeting
Meeting on 12 Nov 2025: quarterly results
Aug 2025
1 Aug · Board meeting
Meeting on 12 Aug 2025: annual general meeting and quarterly results
May 2025
30 May · Board meeting
21 May · Board meeting
Meeting on 30 May 2025: audited results and final dividend
Feb 2025
4 Feb · Board meeting
Meeting on 12 Feb 2025: quarterly results
Nov 2024
26 Nov · Board meeting
Meeting on 26 Nov 2024: rights issue26 Nov · Board meeting
6 Nov · Board meeting
Meeting on 14 Nov 2024: quarterly results
Aug 2024
14 Aug · Board meeting
6 Aug · Board meeting
Meeting on 14 Aug 2024: increase in authorised capital and quarterly results
May 2024
30 May · Board meeting
21 May · Board meeting
Meeting on 30 May 2024: audited results and final dividend
Feb 2024
15 Feb · Board meeting
Meeting on 20 Feb 2024: rights issue of equity shares2 Feb · Board meeting
Meeting on 10 Feb 2024: quarterly results
Nov 2023
8 Nov · Board meeting
Oct 2023
30 Oct · Board meeting
Meeting on 8 Nov 2023: quarterly results
Sep 2023
25 Sep · Board meeting
Meeting on 25 Sep 2023
Aug 2023
4 Aug · Board meeting
Meeting on 14 Aug 2023: quarterly results, annual general meeting, bonus issue and increase in authorised capital
May 2023
15 May · Board meeting
Meeting on 22 May 2023: dividend and audited results
Mar 2023
10 Mar · Board meeting
6 Mar · Board meeting
Meeting on 10 Mar 2023: preferential issue of shares
Feb 2023
13 Feb · Board meeting